entertainment -WSS

entertainment

author：focus 2025-09-06 03:39:52 - browse：1881

Five elderly people have been blinded in one eye by a severe side effect after receiving injections of a newly approved treatment for eye disease from Apellis Pharmaceuticals. The frequency of this side effect — a severe type of eye inflammation — is low but its cause remains unknown.

The new safety information related to the Apellis drug, called Syfovre, was presented Saturday by a committee of eye disease experts at the annual meeting of the American Society of Retinal Specialists (ASRS).

Apellis cooperated with the ASRS analysis but the company also announced its own internal review Saturday that found fewer cases of retinal occlusive vasculitis, a type of severe eye inflammation that blocks blood flow to the retina and can result in blindness. The rate of retinal occlusive vasculitis reported remains “very rare,” the company said, adding that there is no evidence linking the drug product or its manufacturing to the severe side effect.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Stem cell biologist probes earliest stages of human development

WSS

Curing rare childhood diseases will falter unless Congress steps up

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

Health care court cases: Humana, Sutter, Novant

IVF doctors demand details after CooperSurgical lawsuit

Stem cell biologist probes earliest stages of human development

Ancient Greek ideas underpin modern concepts of pregnancy

hotspot

entertainment

hotspot

Medicare details structure of new drug price negotiation program

Change Healthcare: What is it, why does its cyberattack matter?

United colonoscopy coverage change 'may cost lives,' doctors say

Why Talkspace is targeting Medicare, a tricky market

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Medicare drug price negotiation hearing pits pharma v Biden admin

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Change Healthcare: What is it, why does its cyberattack matter?

Hollywood unions extend contract negotiations for actors

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

focus

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Coercive sterilizations revealed by STAT prompt outrage

Families look for replacement for GSK asthma drug Flovent

Moderna says combo Covid

Why Talkspace is targeting Medicare, a tricky market

Harvard's David Sinclair gets blowback over aging

knowledge

Wikipedia

knowledge

hotspot